|Videos|August 4, 2021
Integrated Early Phase to Commercial Drug Substance to Drug Product
Author(s)Lonza
In this 15-minute talk, David K. Lyon, PhD, Senior Fellow of Research, Lonza, discusses a flexible, integrated model supporting over 600 small molecule therapies.
Related Content
Trending on Pharmaceutical Technology
1
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
2
Technology Transfer: Success Drivers and Obstacles Explained
3
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
4
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
5